Roots Analysis has done a detailed study on “Aseptic Fill Finish Market, 2023-2035”, covering key aspects of the industry and identifying future growth opportunities.
Key Market Insights
- Over 175 companies claim to offer fill / finish services for various types of biopharmaceutical drug products; the growth initiatives, in this segment, are being led by large and mid-sized players
- More than 70% of the service providers offer fill / finish for proteins and peptides; in addition, ~80% of the players have the required capabilities to carry out lyophilization operations
- Around 125 industry players offer fill / finish services for various types of small molecule drug products, across different scales of operation
- Leveraging their expertise, 85% stakeholders extend services for labelling and packaging, both for clinical and commercial scale operations
- In order to expand their aseptic fill / finish service portfolios and gain access to emerging technologies, companies are actively entering into strategic partnerships
- The aseptic fill finish market is likely to grow at a CAGR of ~11%, till 2035; this opportunity is expected to be well distributed across different types of molecules, packaging containers and drug products
- In the long-term, the US (~30%) is likely to significantly contribute towards the market growth, followed by Asia-Pacific countries; specifically, within Europe, Germany and France are like to account for ~5% market share, each
Table of Contents
TABLE OF CONTENTS
1. PREFACE
1.1. Chapter Overview
1.2. Key Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Contract Manufacturing
3.3. Commonly Outsourced Operations in Biopharmaceutical Industry
3.4. Basic Guidelines for Selecting a Fill / Finish Service Provider
3.5. Advantages of Outsourcing Fill / Finish Operations
3.6. Risks and Challenges Associated with Outsourcing Fill / Finish Operations
3.7. Concluding Remarks
4. ASEPTIC FILL FINISH SERVICE PROVIDERS LANDSCAPE
4.1. Chapter Overview
4.2. Aseptic Fill / Finish: Service Providers Landscape
5. BIOLOGICS FILL / FINISH SERVICE PROVIDERS LANDSCAPE
5.1. Chapter Overview
5.2. Biologics Fill / Finish: Service Providers Landscape
6. SMALL MOLECULE FILL / FINISH SERVICE PROVIDERS LANDSCAPE
6.1. Chapter Overview
6.2. Small Molecule Fill / Finish: Service Providers Landscape
7. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA
7.1. Chapter Overview
7.2. Companies Offering Aseptic Fill / Finish Services for Biologics
7.2.1. AbbVie Contract Manufacturing
7.2.1.1. Company Snapshot
7.2.1.2. Financial Information
7.2.1.3. Service Portfolio
7.2.1.4. Fill / Finish Services Offered
7.2.1.5. Recent Developments and Future Outlook
7.2.2. BioPharma Solutions
7.2.3. BioReliance
7.2.4. Catalent Biologics
7.2.5. Charles River Laboratories
7.2.6. Patheon
7.3. Companies Offering Aseptic Fill / Finish Services for Small Molecules
7.3.1.1. Pfizer CentreOne
7.3.1.2. Company Snapshot
7.3.1.3. Service Portfolio
7.3.1.4. Fill / Finish Services Offered
7.3.1.5. Recent Developments and Future Outlook
7.3.2. Plastikon Healthcare
7.3.3. Sharp Services
8. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN EUROPE
8.1. Company Overview
8.2. Companies Offering Aseptic Fill / Finish Services for Biologics
8.2.1. Boehringer Ingelheim BioXcellence
8.2.1.1. Company Snapshot
8.2.1.2. Financial Information
8.2.1.3. Service Portfolio
8.2.1.4. Fill / Finish Services Offered
8.2.1.5. Recent Developments and Future Outlook
8.2.2. Fareva
8.2.3. GlaxoSmithKline
8.2.4. Lonza
8.2.5. Pierre Fabre
8.2.6. Wacker Biotech
8.3. Companies Offering Aseptic Fill / Finish Services for Small Molecules
8.3.1. Aenova
8.3.2. APL
8.3.3 CordenPharma
8.3.4. Delpharm
8.3.5 PiSA Farmaceutica
8.4 Companies Offering Aseptic Fill / Finish Services for Biologics and Small Molecules
8.4.1 Fresenius Kabi
8.4.2 Recipharm
9. COMPANY PROFILES: ASEPTIC FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC
9.1 Company Overview
9.2 Companies Offering Aseptic Fill / Finish Services for Biologics
9.2.1 Asymchem
9.2.2. Samsung Biologics
9.2.3. Syngene
9.2.4. Takara Bio
9.2.5. WuXi Biologics
9.2.6. Hetero Drugs
9.2.7. Intas Pharmaceuticals
9.3. Companies Offering Aseptic Fill / Finish Services for Small Molecules
9.3.1. Siegfried
9.3.2. Wockhardt
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Aseptic Fill / Finish Service Providers: List of Partnerships and Collaborations
11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology
11.3. Overall Aseptic Fill / Finish Services Market, 2023-2035
11.4. Aseptic Fill / Finish Services Market for Biologics, 2023-2035
11.5. Aseptic Fill / Finish Services Market for Small Molecules, 2023-2035
12. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING
12.1. Chapter Overview
12.2. Role of Robotic Systems in Pharmaceutical Industry
12.3. Role of Robotic Systems in Fill / Finish Operation
12.4. Contract Service Providers: List of Fill / Finish Equipment
12.5. Companies Providing Robots for Use in the Pharmaceutical Industry
12.6. Companies Providing Isolator based Aseptic Filling Systems
12.7. Concluding Remarks
13. CASE STUDY: READY-TO-USE PACKAGING COMPONENTS FOR ASEPTIC FILL / FINISH
13.1. Chapter Overview
13.2. Role of Ready-to-Use Packaging Components in Aseptic Fill / Finish Operations
13.3. Companies Providing Ready-to-Use Packaging Components
13.4. Concluding Remarks
14. CONCLUDING REMARKS
15. EXECUTIVE INSIGHTS
15.1 Chapter Overview
15.2 IDT Biologika
15.3 Cytovance Biologics
15.4. Syngene
15.5 oncomed manufacturing
15.6 Yposkesi
15.7 HALIX
16. APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
You may also be interested in the following titles:
Conjugation and Labeling Services Market
Key Trends in Non-Viral Transfection Market
Roots Analysis Consulting – the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
